MedPath

KOOTENAI HEALTH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial

Phase 4
Withdrawn
Conditions
SARS-CoV-2 Pneumonia
COVID-19
Interventions
First Posted Date
2020-05-11
Last Posted Date
2021-02-05
Lead Sponsor
Kootenai Health
Registration Number
NCT04382625
Locations
🇺🇸

Kootenai Health, Coeur d'Alene, Idaho, United States

A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip and Knee Arthroplasty

First Posted Date
2015-09-07
Last Posted Date
2019-10-18
Lead Sponsor
Kootenai Health
Target Recruit Count
239
Registration Number
NCT02543801
© Copyright 2025. All Rights Reserved by MedPath